Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026)

Tandem Diabetes Care has reported Retained Earnings for 14 years, with the latest figure at -$1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 8.02% year-over-year to -$1.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.3 billion (down 8.02% YoY), and the FY2025 full-year result was -$1.3 billion, down 19.54% from the prior year.
• Retained Earnings for Q1 2026 stood at -$1.3 billion, down from -$1.3 billion in the prior quarter.
• The five-year high for Retained Earnings was $1.4 million in Q4 2023, with the low at -$1.3 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$733.6 million across 5 years, with a median of -$921.8 million in 2023.
• Annual changes were most pronounced in 2022 — Retained Earnings slumped 5095357.14% — and 2023, when it soared 175.34%.
• Tandem Diabetes Care's Retained Earnings stood at -$1.8 million in 2022, then soared by 175.34% to $1.4 million in 2023, then sank by 76639.44% to -$1.0 billion in 2024, then dropped by 19.54% to -$1.3 billion in 2025, then fell by 1.63% to -$1.3 billion in 2026.
• The last three Retained Earnings figures came in at -$1.3 billion (Q1 2026), -$1.3 billion (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.